# TOBRAMYCIN SULFATE
> **ANDA209621** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2021-02-11
## Drug
- **FDA Application Number:** ANDA209621
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOBRAMYCIN SULFATE
- **Generic name:** TOBRAMYCIN
- **Active ingredients:** TOBRAMYCIN SULFATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Gland Pharma Limited
- **First approval:** 2021-02-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209621)
---
*AI Analytics · CC0 1.0*